NCT00699517 2015-12-21
A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies
Sanofi
Phase 3 Completed
Clinical Trials
10 trialsNCT01263886 2015-12-21
DISRUPT
Sanofi
Phase 2 Completed
NCT01332656 2015-12-21
OPSALIN
Sanofi
Phase 2 Completed
NCT01293630 2015-10-30
A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors
Sanofi
Phase 1 Completed
NCT01193595 2014-12-03
Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid Tumors
Sanofi
Phase 1 Completed
NCT00968916 2014-09-19
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid Tumors
Sanofi
Phase 1 Completed
NCT01907685 2013-07-25
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid Tumors
Sanofi
Phase 1 Completed
NCT00719524 2013-03-11
AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid Tumor
Sanofi
Phase 1 Completed
NCT01063946 2011-12-21
A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid Tumor
Sanofi
Phase 1 Completed
NCT01021150 2011-06-13
Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid Tumors
Sanofi
Phase 1 Completed